StockData
GSK plc logo

GSK plc (GSK) stock

GSKNYSEPharmaceutical PreparationsAlso trades as GLAXF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Score 9/30
$49.24−1.17 (-2.32%)

Close on Nov 17, 2026Market cap $106.25BP/E 13.4Yield –

How the market prices GSK

Each ratio against its own distribution since 2016, from month-end prices and the figures reported at the time

GSK trades at 13.4× its earnings, against a median of 15.3× since 2016 — on the cheap side of its own range.

The shaded bar covers the 5th to 95th percentile of month-end values since 2016, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to earnings since 2016

Median 15.3×, today 13.4×

What GSK keeps of every dollar

Trailing twelve months, from revenue down to net income. Grey columns are what comes out.

Margins against the industry

Gross margin72.4%
Operating margin24.3%
EBITDA margin31.4%
Pretax margin22.7%
Net margin17.5%
Free cash flow margin19.6%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it earns on the capital it uses

Trailing twelve months over average capital

Return on equity38.0%
Return on assets9.48%
Return on invested capital23.4%
Return on capital employed20.0%

How hard the assets work

Revenue per dollar of assets0.54
Inventory turns a year1.56
Revenue per employee£65.33K
Profit per employee£11.43K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How fast it is growing

Trailing twelve months against a year earlier, and the compound annual rate over three and five fiscal years

Last 12 months3-year, a year5-year, a yearIndustry median

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Borrowings exceed cash by £14.32B, or 1.4 times a year of EBITDA. That is 14.7% of the £94.32B it would cost to buy the business outright.

Total debt£17.72B
Cash and short-term investments£3.40B
EBITDA, trailing twelve months£10.25B
Free cash flow, trailing twelve months£6.39B

Leverage and liquidity

Debt to equity1.08
Debt to EBITDA1.73
Net debt to EBITDA1.40
Debt to free cash flow2.77
Current ratio0.82
Quick ratio0.51

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Altman Z-Score

Five ratios that together predicted bankruptcy within two years.

2.19
DistressGrey zoneSafe

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

9 of 9 tests passed

Beneish M-Score

Eight variables that flag accounts shaped to look better than they are.

-2.46
No flagManipulation risk

Price against two rules of thumb

Graham's number and Lynch's fair value, both derived from current earnings.

Graham 10.89 GBPPrice 49.24 GBP

What comes back to shareholders

Trailing twelve months against the market value at the latest close

Earnings yield7.11%
Free cash flow yield7.95%
Buyback yield1.69%
Shareholder yield1.69%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Dividends out of earnings

45%
Room to spareMost of itMore than it makes

Dividends out of free cash flow

40%
Room to spareMost of itMore than it makes

How the shares have traded

Total return includes reinvested dividends, to the close on Nov 17, 2026

Relative strength index, 14 days

How much of the recent move has been upward. Extremes are where traders look for a turn.

46
OversoldNeutralOverbought

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

GSKS&P 500
PeriodGSKS&P 500DifferenceGSK per yearS&P 500 per year
1 month-0.5%-4.0%+3.5 pts
3 months-2.1%-5.0%+2.9 pts
Year to date+3.1%+8.2%−5.2 pts
1 year+6.3%+11.2%−4.9 pts
3 years+55.7%+68.5%−12.8 pts+15.9%+19.0%
5 years+41.7%+67.3%−25.6 pts+7.2%+10.8%
10 years+101.2%+291.6%−190.4 pts+7.2%+14.6%

How much it moves

Volatility, 1 year26.4%
Volume against its 90-day average0.71

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

16M GSK shares were sold short on Oct 30, 2026, up 10.8% from the previous report. At recent volumes it would take 3.2 days to buy them back. Over the last 20 sessions, 42.7% of the volume reported to FINRA was short selling.

Shares sold shortDays to cover
Days of volume to buy it back3.18

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202616,148,828+10.8%5,077,0373.2
Oct 15, 202614,579,567-1.5%6,820,7822.1
Sep 30, 202614,797,116+1.0%3,575,7684.1
Sep 15, 202614,652,083+8.2%2,658,0735.5
Aug 31, 202613,546,612-8.3%2,831,3554.8
Aug 14, 202614,778,190+1.8%3,317,1554.5
Jul 31, 202614,516,962+5.5%5,678,7302.6
Jul 15, 202613,759,806+7.9%3,093,1224.5
Jun 30, 202612,755,267+51.9%3,847,8463.3
Jun 15, 20268,398,074-14.0%4,276,0072.0
May 29, 20269,768,845-28.0%3,084,8593.2
May 15, 202613,570,360+2.5%3,669,3313.7

Every measure, in full

97 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
Aug 14, 2026
Fundamentals through
Dec 31, 2025
Share price as of
–

Valuation ratiosIndustry

Market Cap
£80.42B
–
Enterprise Value
£94.32B
–
PE Ratio
13.43
–
PS Ratio
2.46
–
PB Ratio
4.91
–
P/FCF Ratio
12.58
–
P/OCF Ratio
10.39
–

Enterprise valuationIndustry

EV / Sales
2.89
–
EV / EBIT
11.89
–
EV / FCF
14.75
–

Share statisticsIndustry

Shares Change (YoY)
-0.60%
–
Float
4.32B
–
Shares Held by Insiders
0.00%
–
Shares Held by Institutions
8.03%
–

Short sellingIndustry

Short Interest
16M
–
Short Interest Change
10.8%
–
Days to Cover
3.18
–

Stock price statisticsIndustry

Price Change (1 Week)
-3.88%
–
Price Change (1 Month)
-0.44%
–
Price Change (3 Months)
-6.88%
–
Price Change (6 Months)
-3.55%
–
Price Change (YTD)
0.41%
–
Price Change (1 Year)
4.37%
–
Price Change (3 Years)
39.9%
–
Price Change (5 Years)
-3.22%
–
Price Change (10 Years)
5.39%
–
Average Volume (10 Days)
3M
–
Average Volume (20 Days)
4M
–
Average Volume (90 Days)
4M
–
Relative Volume
0.71
–
Relative Strength Index (14)
45.9
–
Volatility (1 Year)
26.4%
–

MarginsIndustry

Gross Margin
72.4%
–
Pretax Margin
22.7%
–
EBITDA Margin
31.4%
–
FCF Margin
19.6%
–

Returns on capitalIndustry

Return on Equity (ROE)
38.0%
–
Return on Assets (ROA)
9.48%
–
Return on Invested Capital (ROIC)
23.4%
–
Return on Capital Employed (ROCE)
20.0%
–

Financial positionIndustry

Current Ratio
0.82
–
Quick Ratio
0.51
–
Debt / Equity
1.08
–
Debt / EBITDA
1.73
–
Debt / FCF
2.77
–
Net Debt / EBITDA
1.40
–
Interest Coverage
11.32
–

GrowthIndustry

Revenue Growth (YoY)
4.11%
–
Net Income Growth (YoY)
122.0%
–
EPS Growth (YoY)
123.2%
–
FCF Growth (YoY)
24.0%
–
Revenue Growth (3Y CAGR)
3.66%
–
Revenue Growth (5Y CAGR)
6.05%
–
EPS Growth (3Y CAGR)
-27.6%
–
EPS Growth (5Y CAGR)
-0.54%
–

EfficiencyIndustry

Asset Turnover
0.54
–
Inventory Turnover
1.56
–
Revenue Per Employee
£65.33K
–
Profits Per Employee
£11.43K
–
Employee Count
500,000
–

Income statement (TTM)Industry

Revenue
£32.67B
–
Gross Profit
£23.65B
–
Pretax Income
£7.40B
–
Net Income
£5.72B
–
EBITDA
£10.25B
–
EPS (Diluted)
1.39 GBP
–

Balance sheetIndustry

Total Debt
£17.72B
–
Net Cash (Debt)
-£14.32B
–
Net Cash Per Share
-3.32 GBP
–
Equity (Book Value)
£16.38B
–
Book Value Per Share
3.79 GBP
–
Tangible Book Value
-£7.39B
–
Working Capital
-£3.88B
–

Cash flow (TTM)Industry

Capital Expenditures
-£1.35B
–
Free Cash Flow
£6.39B
–
FCF Per Share
1.48 GBP
–

Dividends and yieldsIndustry

Earnings Yield
7.11%
–
FCF Yield
7.95%
–
Buyback Yield
1.69%
–
Shareholder Yield
1.69%
–
Payout Ratio
44.9%
–
FCF Payout Ratio
40.1%
–

Taxes and interestIndustry

Interest Expense
£701.00M
–
Income Tax
£1.11B
–
Effective Tax Rate
15.0%
–

Scores and fair valueIndustry

Graham Number
10.89 GBP
–
Graham Upside
-41.6%
–
Altman Z-Score
2.19
–
Piotroski F-Score
9
–
Beneish M-Score
-2.46
–

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?